Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
RFK Jr. names eight new ACIP members, including popular vaccine critic Robert Malone
4 weeks ago
Pharma
FDA+
Trump officials seek price details and weigh consumer sales as they examine most favored nation plan
5 weeks ago
Pharma
Trump’s HHS urges against reviving Chamber of Commerce’s IRA lawsuit
5 weeks ago
Pharma
Law
Federal officials schedule three listening sessions this summer to address drug competition
5 weeks ago
Pharma
Exclusive: Organoid startup raises $21M to test drugs and vaccines in human lymph nodes-in-a-dish
5 weeks ago
Startups
R&D
House appropriators call for FDA tweaks on accelerated approvals, biosimilars
5 weeks ago
R&D
FDA+
Nuvation Bio scores first FDA approval for new lung cancer drug
5 weeks ago
Pharma
FDA+
Watch Post-Hoc Live: What happens when AI thinks in ways we can’t understand?
5 weeks ago
Editor's note
R&D
Cabaletta Bio shares CAR-T results in three autoimmune conditions
5 weeks ago
R&D
Lilly pledges more than $650M to muscle health biotech; Cogent gets $50M
5 weeks ago
News Briefing
Vaxart shares surge on norovirus vaccine data as it seeks funding for new trials
5 weeks ago
R&D
Have sky-high sales projections set the obesity market up to fail?
5 weeks ago
Pharma
In Focus
Updated: Novo makes another cardiometabolic deal focused on oral medicines
5 weeks ago
Startups
Deals
BMS’ RayzeBio inks radiopharma deal in prostate cancer for $350M upfront
5 weeks ago
Deals
R&D
Basecamp pitches a fix for AI bio's 'data wall'
5 weeks ago
AI
Gene therapy biotech SpliceBio gets $135M shortly after starting first clinical trial
5 weeks ago
Financing
Startups
Vertex lays off 125 workers after type 1 diabetes cell therapy failed study in March
5 weeks ago
People
Pharma
Argenx says its drug Vyvgart looks promising in two more autoimmune diseases
5 weeks ago
R&D
Pharma
FDA’s Makary says he wasn’t part of decision to gut ACIP, defers possible VRBPAC changes to Prasad
5 weeks ago
R&D
Pharma
FDA places hold on Gilead's studies of HIV treatment pill combo
5 weeks ago
R&D
FDA+
Post-Hoc Live: The fallout from RFK Jr.’s firing of ACIP, with ex-CDC Director Mandy Cohen
5 weeks ago
Editor's note
Insmed’s stock rallies on PAH data; Unicycive aims to resolve CDMO issues
5 weeks ago
News Briefing
Next in line for a digital health IPO
5 weeks ago
Health Tech
Exclusive: Rebooting dead human brains, a biotech startup seeks to reinvent early drug testing work
5 weeks ago
R&D
In Focus
First page
Previous page
8
9
10
11
12
13
14
Next page
Last page